Stroke Virtual Grand Rounds
Peripheral Artery Disease -
Underdiagnosed and Undertreated
 |
||
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: October 14, 2011
Expiration Date: October 14, 2013
Estimated Time of Completion: 1 hour
Description
The purpose of this activity is to describe the risk factors and symptoms of peripheral artery disease (PAD) and assessment and management strategies for patients with PAD.
Learning Objectives
- Discuss risk factors for developing PAD.
- Describe the symptoms of PAD and methods to assess its severity.
- Evaluate the risks and benefits associated with therapies for PAD.
Target Audience
This activity is directed to neurologists, primary care physicians, and other healthcare professionals who manage patients with cerebrovascular disease.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
Edward Manno, MD
Head, Neurocritical Care Unit
Cleveland Clinic
Cleveland, Ohio
Faculty
Jeffrey W. Olin, DO, FACC, FAHA
Professor of Medicine (Cardiology)
Director of Vascular Medicine and Vascular Diagnostic Laboratory
Mount Sinai School of Medicine
Zena and Michael A. Wiener Cardiovascular Institute and
Marie-Jose´e and Henry R. Kravis Center for Cardiovascular Health
Mount Sinai Medical Center
New York, New York
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Jeffrey W. Olin, DO, FACC, FAHA |
||
| Genzyme Corporation; Merck & Co., Inc. | Consulting | |
| Genzyme Corporation; Merck & Co., Inc. |
Membership on Advisory Committee or Review Panel |
|
The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Edward Manno, MD
All other planners, CME staff, and content reviewers have no relevant financial relationships to disclose.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges
an educational grant for support of this activity from:
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
This CME activity was produced by the
Cleveland Clinic Center for Continuing Education
and
